Protagenic Therapeutics, Inc. PTIXW NASDAQ · Healthcare · United States
$0.02 +0.00% +$0.00
Summary
73 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 35,481 USD is left as net profit.
- It earns 149 USD a year on every 100 USD of invested capital.
- It has no debt and holds $362.5K in cash.
What to watch
- It passes only 2 of the 9 points of the Piotroski financial health test.
- For every 100 USD of bills due within a year it has 29 USD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
Revenue (USD)
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.